» Articles » PMID: 4051554

Production of Acid and Neutral Cysteine-proteinase Inhibitors by a Cultured Human Skin Epithelium Cell Line

Overview
Specialty Dermatology
Date 1985 Jan 1
PMID 4051554
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Human skin epithelial-like cells (NCTC-strain 2544) were grown in RPMI-1640 medium supplemented with foetal calf serum for up to 2 weeks. The culture medium and extracts made from the cells were subjected to gel-filtration chromatography in a Sephacryl S-200 column for fractionation of the proteins. The fractions were assayed for acid and neutral cysteine-proteinase inhibitor (ACPI, NCPI) using time-resolved fluoroimmunoassay and radioimmunoassay, and the cysteine-proteinase-inhibiting activities were assayed using papain. Free NCPI, i.e. a molecule with isoelectric variants at pHs 6.0 and 6.5, which has an Mr of around 12,000 and is capable of inhibiting papain, was detected both in the culture medium and in the cells. Immunodiffusion studies revealed its immunological identity with human spleen-derived NCPI. The amount of NCPI increased during the incubation period. ACPI--characterized as a molecule having an isoelectric point of 4.9, an Mr of about 12,000, papain-inhibiting capacity and antigenic reactivity with spleen-derived ACPI--was not detected in the culture medium. It was, however, detected in the cells after 2 weeks in culture. These data prove that ACPI and NCPI are synthesized by the NCTC-2544 cells under the present culture conditions.

Citing Articles

Clinical relevance of cathepsin B-like enzyme activity and cysteine proteinase inhibitor in melanocytic tumours.

Yoshii A, Kageshita T, Tsushima H, Ono T Arch Dermatol Res. 1995; 287(2):209-13.

PMID: 7763093 DOI: 10.1007/BF01262334.


Separation and partial characterization of four cysteine proteinases from a human epidermal cell line.

Joronen I, Hopsu-Havu V Arch Dermatol Res. 1987; 279(8):524-9.

PMID: 3501707 DOI: 10.1007/BF00413284.


A 43-kDa papain inhibitor produced by a cultured human epidermal cell line.

Hopsu-Havu V, Joronen I, Rinne A, Jarvinen M Arch Dermatol Res. 1986; 278(5):372-6.

PMID: 3092748 DOI: 10.1007/BF00418165.

References
1.
Jarvinen M, Rinne A . Human spleen cysteineproteinase inhibitor. Purification, fractionation into isoelectric variants and some properties of the variants. Biochim Biophys Acta. 1982; 708(2):210-7. View

2.
Ree K, Johnsen A, Rugstad H, Bakka A, Hovig T . Characterization of a human epithelial cell line with special reference to its ultrastructure. Acta Pathol Microbiol Scand A. 1981; 89(2):73-80. DOI: 10.1111/j.1699-0463.1981.tb00192.x. View

3.
Kopitar M, Stern F, Marks N . Cerebrocystatin suppresses degradation of myelin basic protein by purified brain cysteine proteinase. Biochem Biophys Res Commun. 1983; 112(3):1000-6. DOI: 10.1016/0006-291x(83)91717-5. View

4.
Jarvinen M . Purification and properties of two protease inhibitors from rat skin inhibiting papain and other SH-proteases. Acta Chem Scand B. 1976; 30(10):933-40. DOI: 10.3891/acta.chem.scand.30b-0933. View

5.
Hopsu-Havu V, Jarvinen M, Rinne A . Separation of cysteine proteinase inhibitors from psoriatic scale. Br J Dermatol. 1983; 109 Suppl 25:77-85. View